However, inhibition of aromatase, which reduces estradiol levels, significantly disrupts GH production, revealing estradiol as a critical mediator of GH’s effects in prostate cancer (Link et al., 1986; Birzniece and Ho, 2021). The gene discussed is GH1; the disease is Familial prostate cancer.